Abeona Therapeutics Announces Acceptance of Abstract on EB-101 Phase 3 VIITAL™ Study Results for Oral Presentation at International Societies for Investigative Dermatology (ISID) 2023 Meeting
NEW YORK and CLEVELAND, March 16, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO)…
Helport AI Opens Thailand Office
playX Receives the ‘Enterprise Award’ at the Asia Golden Star Awards in Tokyo
Zhibao Technology Announces Receipt of Nasdaq Deficiency Letter
Fairfax County and Penzance Officials Break Ground on Next-Generation Digital Infrastructure Project to Power the World’s Deep Tech Future